Thromb Haemost 1995; 74(02): 791-792
DOI: 10.1055/s-0038-1649814
Scientific and Standardization Committee Communications
Schattauer GmbH Stuttgart

Diagnosis and Treatment of Venous Thromboembolism in Children and Adolescents

On behalf of the Subcommittee on Perinatal Haemostasis (M. Andrew, Chairman) of the Scientific and Standardization Committee of the ISTH
M David
The Hamilton Civic Hospitals, Research Centre, Henderson General Division, Children’s Hospital at Chedoke-McMaster, Hospital for Sick Children, Hamilton, Ontario, Canada
,
M Manco-Johnson
The Hamilton Civic Hospitals, Research Centre, Henderson General Division, Children’s Hospital at Chedoke-McMaster, Hospital for Sick Children, Hamilton, Ontario, Canada
,
M Andrew
The Hamilton Civic Hospitals, Research Centre, Henderson General Division, Children’s Hospital at Chedoke-McMaster, Hospital for Sick Children, Hamilton, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Publication Date:
06 July 2018 (online)

 
  • References

  • 1 Schmidt B, Andrew M. Report of Scientific and Standardization Subcommittee on Neonatal Hemostasis. Diagnosis and Treatment of Neonatal Thrombosis Thromb Haemost 1992; 67 (03) 381-382
  • 2 Andrew M, Adams M, David M. Venous thromboembolic complications (VTE) in children: First analyses of the Canadian Registry of VTE. Blood 1994; 83 (05) 1251-1257
  • 3 Andrew M, Marzinotto V, Massicotte P. et al Heparin therapy in pediatric patients: A prospective cohort study. Pediatr Res 1994; 35: 78-83
  • 4 David M, Andrew M. Venous thromboembolic complications in children. J Pediatr 1993; 123 (03) 337-346
  • 5 Perlmutt L, Fellows KE. Lower extremity deep vein thrombosis in children. Pediatr Radiol 1983; 13: 266-268
  • 6 O’Brodovich HM, Coates G. Quantitative ventilation-perfusion lung scans in infants and children: Utility of a submicronic radiolabeled aerosol to assess ventilation. J Pediatr 1984; 105: 377-383
  • 7 Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 30 (08) 517-522
  • 8 Andrew M, Vegh P, Johnston M. et al Maturation of the hemostatic system during childhood. Blood 1992; 80 (08) 1998-2005
  • 9 Andrew M, Marzinotto V, Brooker LA. et al Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb Haemost 1994; 71 (03) 265-269
  • 10 Cumow A, Idowu J, Behrens E. et al Urokinase therapy for Silastic catheter- induced intravascular thrombi in infants and children. Arch Surg 1985; 120 (11) 1237-1240
  • 11 Levy M, Benson LN, Burrows PE. et al Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 1991; 118 (03) 467-472
  • 12 Mirro Jr J, Rao BN, Stoked DC. et al A prospective study of Hickman/ Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 1989; 7: 214-222
  • 13 Morris JB, Occhionero ME, Gauderer MW L. et al Totally implantable vascular access devices in cystic fibrosis: A four-year experience with fifty- eight patients. J Pediatr 1990; 117 (01) 82-85
  • 14 Winthrop AL, Wesson DE. Urokinase in the treatment of occluded central venous catheters in children. J Pediatr Surg 1984; 19 (05) 536-538
  • 15 Bagnall HA, Gomperts E, Atkinson JB. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children. Pediatrics 1989; 83 (06) 963-966